139 related articles for article (PubMed ID: 234854)
21. [Comparability of adjuvant disease of rats with human diseases].
Schmidt K; Ott VR
Schweiz Med Wochenschr; 1973 Aug; 103(31):1099-103. PubMed ID: 4796194
[No Abstract] [Full Text] [Related]
22. Bacillus Calmette-Guerin and bladder cancer.
Razack AH
Asian J Surg; 2007 Oct; 30(4):302-9. PubMed ID: 17962138
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of insulin secretory response of rats by cell wall skeleton extracted from BCG cell wall.
Kawata T; Itaya K
Jpn J Pharmacol; 1982 Oct; 32(5):929-31. PubMed ID: 6217366
[No Abstract] [Full Text] [Related]
24. The effect of adjuvant disease on serum amylase in the rat.
Gingold JL; DiPasquale G
Proc Soc Exp Biol Med; 1975 Mar; 148(3):653-5. PubMed ID: 1079350
[No Abstract] [Full Text] [Related]
25. Inhibition of experimental metastatic spread by nonspecific stimulants.
Arnold W; Muresian TM; Kiricuta I; Graffi A
Oncology; 1977; 34(4):156-8. PubMed ID: 917448
[TBL] [Abstract][Full Text] [Related]
26. Etiologic models of rheumatoid arthritis.
JAMA; 1969 Dec; 210(9):1754. PubMed ID: 5394673
[No Abstract] [Full Text] [Related]
27. Protective Effects of Simvastatin and Hesperidin against Complete Freund's Adjuvant-Induced Rheumatoid Arthritis in Rats.
Ahmed YM; Messiha BA; Abo-Saif AA
Pharmacology; 2015; 96(5-6):217-25. PubMed ID: 26345515
[TBL] [Abstract][Full Text] [Related]
28. Intravesical bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: A review.
Saluja M; Gilling P
Int J Urol; 2018 Jan; 25(1):18-24. PubMed ID: 28741703
[TBL] [Abstract][Full Text] [Related]
29. [Pulmonal bacillus Calmette-Guérin infection two years after intravesical bacillus Calmette-Guérin installation].
Harbjerg JL; Bjerre CC; Lillebæk T; Weinreich UM
Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497624
[TBL] [Abstract][Full Text] [Related]
30. HMGB1 release by urothelial carcinoma cells is required for the in vivo antitumor response to Bacillus Calmette-Guérin.
Zhang G; Chen F; Cao Y; Johnson B; See WA
J Urol; 2013 Apr; 189(4):1541-6. PubMed ID: 23041342
[TBL] [Abstract][Full Text] [Related]
31. [Arthritis in experimental animals].
Keitel W
Beitr Rheumatol; 1968; 13():164-7. PubMed ID: 5728423
[No Abstract] [Full Text] [Related]
32. Proceedings: Influence of tubercle aggregate size on the severity of adjuvant arthritis in the rat.
Liyanage SP; Currey HL; Vernon-Roberts B
Ann Rheum Dis; 1974 Jul; 33(4):401. PubMed ID: 4213316
[No Abstract] [Full Text] [Related]
33. Proceedings: Resistance of rats to carrageenan and to adjuvant-induced arthritis.
Freeman PC; West GB
Br J Pharmacol; 1972 Feb; 44(2):327P-328P. PubMed ID: 4668602
[No Abstract] [Full Text] [Related]
34. Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors.
Lamm DL; Harris SC; Gittes RF
Invest Urol; 1977 Mar; 14(5):369-72. PubMed ID: 844999
[TBL] [Abstract][Full Text] [Related]
35. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
Lee YT
Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
[TBL] [Abstract][Full Text] [Related]
36. Bacillus calmette-guérin vaccination in a patient treated with infliximab.
Toussirot E; Wendling D
J Rheumatol; 2005 Dec; 32(12):2500-1. PubMed ID: 16331800
[No Abstract] [Full Text] [Related]
37. [SOME CLINICO-HEMATOLOGICAL AND IMMUNOLOGICAL PHENOMENA FOLLOWING THE ACTION OF FREUND'S ADJUVANT ON WHITE RATS].
SURA VV; KOLAEV VA; KONSTATINOVA IV
Biull Eksp Biol Med; 1964 Sep; 58():97-102. PubMed ID: 14273474
[No Abstract] [Full Text] [Related]
38. [Hematologic changes in rats with adjuvant-induced disease. Intravascular clotting and fibrinolysis as a possible factor in the pathogenesis of anemia].
Mikołajew M; Stachurska J; Kałczak M; Lewicka S; Kossakowska M
Reumatologia; 1975; 13(1):47-56. PubMed ID: 1118690
[No Abstract] [Full Text] [Related]
39. A randomized prospective comparison of oral versus intravesical and percutaneous bacillus Calmette-Guerin for superficial bladder cancer.
Lamm DL; DeHaven JI; Shriver J; Crispen R; Grau D; Sarosdy MF
J Urol; 1990 Jul; 144(1):65-7. PubMed ID: 2193172
[TBL] [Abstract][Full Text] [Related]
40. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
